Sfoglia per Autore
Fibrinolytic Proteins and Factor XIII as Predictors of Thrombotic and Hemorrhagic Complications in Hospitalized COVID-19 Patients
2022 Marchetti, M; Gomez-Rosas, P; Russo, L; Gamba, S; Sanga, E; Verzeroli, C; Ambaglio, C; Schieppati, F; Restuccia, F; Bonanomi, E; Rizzi, M; Fagiuoli, S; D'Alessio, A; Gerotziafas, G; Lorini, L; Falanga, A
An unexpected case of recurrence of pulmonary embolism in a patient recovered from COVID19 in full regimen dose of direct oral anticoagulant drug
2021 D'Elia, E; Gori, M; Grosu, A; Iorio, A; Lorini, F; Falanga, A; Di Marco, F; Senni, M
Post-operative heparin reduces early venous thrombotic complications after orthotopic paediatric liver transplantation
2021 Colombo, G; Giaccherini, C; Benzi, A; Ferrari, F; Bonacina, D; Corno, M; Colledan, M; Alessio, M; Bonanomi, E; Nacoti, M; Falanga, A
Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two-year outcomes after the study closure
2021 Pengo, V; Hoxha, A; Andreoli, L; Tincani, A; Silvestri, E; Prisco, D; Fierro, T; Gresele, P; Cafolla, A; De Micheli, V; Ghirarduzzi, A; Tosetto, A; Falanga, A; Martinelli, I; Testa, S; Barcellona, D; Gerosa, M; Denas, G
A microphysiological early metastatic niche on a chip reveals how heterotypic cell interactions and inhibition of integrin subunit β3 impact breast cancer cell extravasation
2021 Crippa, M; Bersini, S; Gilardi, M; Arrigoni, C; Gamba, S; Falanga, A; Candrian, C; Dubini, G; Vanoni, M; Moretti, M
Tissue Plasminogen Activator Levels and Risk of Breast Cancer in a Case-Cohort Study on Italian Women: Results from the Moli-sani Study
2021 Costanzo, S; Parisi, R; De Curtis, A; Gamba, S; Russo, L; Persichillo, M; Panzera, T; Marchetti, M; Cerletti, C; De Gaetano, G; Falanga, A; Donati, M; Iacoviello, L
D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study
2020 Palareti, G; Legnani, C; Antonucci, E; Cosmi, B; Poli, D; Testa, S; Tosetto, A; Ageno, W; Falanga, A; Ferrini, P; Pengo, V; Prandoni, P
Hemostatic biomarkers in occult cancer and cancer risk prediction
2020 Marchetti, M; Falanga, A
Anticoagulation resumption after intracranial hemorrhage in patients treated with VKA and DOACs
2020 Poli, D; Antonucci, E; Vignini, E; Martinese, L; Testa, S; Simioni, P; Pengo, V; Pignatelli, P; Falanga, A; Masciocco, L; Barcellona, D; Ciampa, A; Chiarugi, P; Paparo, C; Ageno, W; Palareti, G; START2 Registry, I
Anticoagulation in thrombocytopenic patients with hematological malignancy: A multinational clinical vignette-based experiment
2020 Leader, A; Ten Cate, V; Ten Cate-Hoek, A; Beckers, E; Spectre, G; Giaccherini, C; Gurevich-Shapiro, A; Krashin, E; Raanani, P; Schouten, H; Falanga, A; Ten Cate, H
Clozapine-induced anemia: A case-report
2020 Eleftheriou, G; Butera, R; Barcella, L; Falanga, A
DOACs and “newer” hemophilia therapies in COVID-19: Reply
2020 Thachil, J; Tang, N; Gando, S; Falanga, A; Cattaneo, M; Levi, M; Clark, C; Iba, T
Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE
2020 Weitz, J; Haas, S; Ageno, W; Goldhaber, S; Turpie, A; Goto, S; Angchaisuksiri, P; Nielsen, J; Kayani, G; Farjat, A; Schellong, S; Bounameaux, H; Mantovani, L; Prandoni, P; Kakkar, A; GARFIELD-VTE, I; Falanga, A
Thrombin generation predicts early recurrence in breast cancer patients
2020 Marchetti, M; Giaccherini, C; Masci, G; Verzeroli, C; Russo, L; Celio, L; Sarmiento, R; Gamba, S; Tartari, C; Diani, E; Vignoli, A; Malighetti, P; Spinelli, D; Kuderer, N; Nichetti, F; Tondini, C; Barni, S; Giuliani, F; Petrelli, F; D'Alessio, A; Gasparini, G; Labianca, R; Santoro, A; De Braud, F; Falanga, A; Hypercan, I
Grey zones on the use of new oral anticoagulants in atrial fibrillation. Expert opinion [Grey zones sull'uso dei nuovi anticoagulanti orali nella fibrillazione atriale. Opinioni degli esperti]
2020 Di Pasquale, G; Iacovoni, A; Filardi, P; Giustozzi, M; De Ponti, R; Falanga, A; Botto, G; De Filippo, P; Gavazzi, A; Sciatti, E; Senni, M; Porcu, M
Fundamental Research in Oncology and Thrombosis 2 (FRONTLINE 2): A Follow-Up Survey
2020 Kakkar, A; Bauersachs, R; Falanga, A; Wong, J; Kayani, G; Kahney, A; Hughes, R; Levine, M
Preface to the Proceedings of the 10th International Conference on Thrombosis and Hemostasis Issues in Cancer, 2020
2020 Falanga, A; Brenner, B; Khorana, A
Anticoagulation in Italian patients with venous thromboembolism and thrombophilic alterations: findings from START2 register study
2020 Margaglione, M; Antonucci, E; D'Andrea, G; Migliaccio, L; Ageno, W; Bucherini, E; Cosmi, B; Falanga, A; Martini, G; Mastroiacovo, D; Paparo, C; Poli, D; Testa, S; Palareti, G
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
2020 Key, N; Khorana, A; Kuderer, N; Bohlke, K; Lee, A; Arcelus, J; Wong, S; Balaban, E; Flowers, C; Francis, C; Gates, L; Kakkar, A; Levine, M; Liebman, H; Tempero, M; Lyman, G; Falanga, A
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research
2020 Bikdeli, B; Madhavan, M; Gupta, A; Jimenez, D; Burton, J; Der Nigoghossian, C; Chuich, T; Nouri, S; Dreyfus, I; Driggin, E; Sethi, S; Sehgal, K; Chatterjee, S; Ageno, W; Madjid, M; Guo, Y; Tang, L; Hu, Y; Bertoletti, L; Giri, J; Cushman, M; Quéré, I; Dimakakos, E; Gibson, C; Lippi, G; Favaloro, E; Fareed, J; Tafur, A; Francese, D; Batra, J; Falanga, A; Clerkin, K; Uriel, N; Kirtane, A; Mclintock, C; Hunt, B; Spyropoulos, A; Barnes, G; Eikelboom, J; Weinberg, I; Schulman, S; Carrier, M; Piazza, G; Beckman, J; Leon, M; Stone, G; Rosenkranz, S; Goldhaber, S; Parikh, S; Monreal, M; Krumholz, H; Konstantinides, S; Weitz, J; Lip, G; Global COVID-19 Thrombosis Collaborative, G
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile